$259.06-5.99 (-2.26%)
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States.
Tenet Healthcare Corporation in the Healthcare sector is trading at $259.06 with a market capitalization of $21.6B. Wall Street consensus targets $285.10 (21 analysts), implying a +10.0% move over the next 12 months. The stock is currently near its 52-week high of $283.05, remaining 24.2% above its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $6.04B↑ | $5.78B↑ | $5.53B↑ | $5.29B↑ | $5.27B |
| Gross Profit | $5.06B↑ | $4.82B↑ | $4.52B↑ | $4.36B↑ | $4.34B |
| Operating Income | $1.44B↑ | $1.29B↑ | $869.00M↑ | $817.00M↓ | $852.00M |
| Net Income | $826.00M↑ | $702.00M↑ | $371.00M↑ | $342.00M↑ | $288.00M |
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services...

PSX, HRTG, THC, CSTM and BLMN have been added to the Zacks Rank #1 (Strong Buy) List on September 8, 2026.

Tenet Healthcare (THC) is drawing fresh attention after a strong Q2 earnings surprise and a higher 2026 adjusted EPS outlook. The company also plans to present at the Wells Fargo Healthcare Conference on September 9, 2026. For context, Tenet Healthcare’s share price has climbed strongly over the past few months, with a 90 day share price return of 62.59% and a year to date share price return of 32.11%. The 3 year total shareholder return of 259.08% points to momentum that has been building...

Tenet (THC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.

Tenet Healthcare's strong Q2, rising EPS estimates and modest valuation contrast with Archrock's misses and falling outlook.

Tenet Healthcare offers an appealing combination of defensive healthcare exposure, improving operating fundamentals, surging earnings estimates, and a modest valuation.